Education
About Us
Working with TipRanks
Follow Us
Scandinavian Real Heart AB (DE:7820)
FRANKFURT:7820
7820 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.82 - €3.90
Previous CloseN/A
Volume0.00
Average Volume (3M)20.00
Market Cap
€6.53M
Enterprise ValueN/A
Total Cash (Recent Filing)€23.72M
Total Debt (Recent Filing)kr6.35M
Price to Earnings (P/E)―
Beta0.37
Next Earnings
Aug 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.42
Shares Outstanding4,998,704
10 Day Avg. Volume0
30 Day Avg. Volume20
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.45
Price to Sales (P/S)0.00
P/FCF Ratio-0.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
7820 FAQ
What was Scandinavian Real Heart AB’s price range in the past 12 months?
Scandinavian Real Heart AB lowest stock price was €0.82 and its highest was €3.90 in the past 12 months.
What is Scandinavian Real Heart AB’s market cap?
Scandinavian Real Heart AB’s market cap is €6.53M.
When is Scandinavian Real Heart AB’s upcoming earnings report date?
Scandinavian Real Heart AB’s upcoming earnings report date is Aug 15, 2025 which is in 78 days.
How were Scandinavian Real Heart AB’s earnings last quarter?
Scandinavian Real Heart AB released its earnings results on May 15, 2025. The company reported -€0.424 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.424.
Is Scandinavian Real Heart AB overvalued?
According to Wall Street analysts Scandinavian Real Heart AB’s price is currently Overvalued.
Does Scandinavian Real Heart AB pay dividends?
Scandinavian Real Heart AB does not currently pay dividends.
What is Scandinavian Real Heart AB’s EPS estimate?
Scandinavian Real Heart AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scandinavian Real Heart AB have?
Scandinavian Real Heart AB has 4,998,704 shares outstanding.
What happened to Scandinavian Real Heart AB’s price movement after its last earnings report?
Scandinavian Real Heart AB reported an EPS of -€0.424 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.419%.
Which hedge fund is a major shareholder of Scandinavian Real Heart AB?
Currently, no hedge funds are holding shares in DE:7820
Company Description
Scandinavian Real Heart AB
Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. It engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, PulsePump, and Sternal Prosthesis products. The company was incorporated in 2007 and is based in Västerås, Sweden.